Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Meijer

Showing results (611-620 of 1,090) with videos related to

Pageof 109
Sort By:
International Journal of Cancer|April 18, 2018
Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-upLise M A De Strooper, Johannes Berkhof, Renske D M Steenbergen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2013
Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudyMaaike G Dijkstra, Dirk van Niekerk, Dorien C Rijkaart, et al.
Viruses|May 28, 2022
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer ScreeningDaniëlle A M Heideman, Anja Oštrbenk Valenčak, Saskia Doorn, et al.
The Journal of Infectious Diseases|December 25, 2016
Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated GirlsRobine Donken, Tessa M Schurink-Van't Klooster, Rutger M Schepp, et al.
Development (Cambridge, England)|September 24, 2024
Unravelling differential Hes1 dynamics during axis elongation of mouse embryos through single-cell trackingYasmine El Azhar, Pascal Schulthess, Marek J van Oostrom, et al.
Journal of Clinical Pathology|May 23, 2006
In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiologyM van Seters, F J W ten Kate, M van Beurden, et al.
Journal of Pediatric Hematology/Oncology|February 26, 2020
Clinical Characteristics of Invasive Fungal Infections in Pediatric Oncology Patients With Solid TumorsVeerle J Ruijters, Natanja Oosterom, Madeleine E M van der Perk, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2012
Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogramHanneke J M Meijer, Oscar A Debats, Mack Roach, et al.
Gynecologic Oncology|June 12, 2019
Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysisStèfanie Dick, Wieke W Kremer, Lise M A De Strooper, et al.
Preventive Medicine|April 17, 2014
Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch womenRemko P Bosgraaf, Pleun J W Ketelaars, Viola M J Verhoef, et al.
Pageof 109

Showing results (611-620 of 1,090) with videos related to

Sort By:
Pageof 109
International Journal of Cancer|April 18, 2018
Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-upLise M A De Strooper, Johannes Berkhof, Renske D M Steenbergen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2013
Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudyMaaike G Dijkstra, Dirk van Niekerk, Dorien C Rijkaart, et al.
Viruses|May 28, 2022
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer ScreeningDaniëlle A M Heideman, Anja Oštrbenk Valenčak, Saskia Doorn, et al.
The Journal of Infectious Diseases|December 25, 2016
Immune Responses After 2 Versus 3 Doses of HPV Vaccination up to 4½ Years After Vaccination: An Observational Study Among Dutch Routinely Vaccinated GirlsRobine Donken, Tessa M Schurink-Van't Klooster, Rutger M Schepp, et al.
Development (Cambridge, England)|September 24, 2024
Unravelling differential Hes1 dynamics during axis elongation of mouse embryos through single-cell trackingYasmine El Azhar, Pascal Schulthess, Marek J van Oostrom, et al.
Journal of Clinical Pathology|May 23, 2006
In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiologyM van Seters, F J W ten Kate, M van Beurden, et al.
Journal of Pediatric Hematology/Oncology|February 26, 2020
Clinical Characteristics of Invasive Fungal Infections in Pediatric Oncology Patients With Solid TumorsVeerle J Ruijters, Natanja Oosterom, Madeleine E M van der Perk, et al.
International Journal of Radiation Oncology, Biology, Physics|April 24, 2012
Magnetic resonance lymphography findings in patients with biochemical recurrence after prostatectomy and the relation with the Stephenson nomogramHanneke J M Meijer, Oscar A Debats, Mack Roach, et al.
Gynecologic Oncology|June 12, 2019
Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysisStèfanie Dick, Wieke W Kremer, Lise M A De Strooper, et al.
Preventive Medicine|April 17, 2014
Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch womenRemko P Bosgraaf, Pleun J W Ketelaars, Viola M J Verhoef, et al.
Pageof 109